Start for free
Start for free
Samlyn Capital logo

Samlyn Capital

North America, New York, United States, New York

Description

Samlyn Capital operates as an investment management company.

Investor Profile

Samlyn Capital has made 6 investments, with 3 in the past 12 months and 17% as lead.

Stage Focus

  • Post Ipo Equity (83%)
  • Series B (17%)

Country Focus

  • United States (100%)

Industry Focus

  • Biotechnology
  • Pharmaceutical
  • Health Care
  • Chemical Engineering
  • Recycling
  • Waste Management
  • Biopharma
  • Health Diagnostics
  • Therapeutics
  • Commercial
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Samlyn Capital frequently co-invest with?

OrbiMed
OrbiMed
North America, New York, United States, New York
Co-Investments: 1
Access Biotechnology
Access Biotechnology
North America, New York, United States, New York
Co-Investments: 1
Sylebra Capital
Sylebra Capital
North America, California, United States, Palo Alto
Co-Investments: 2
Altamont Pharmaceutical Holdings
Altamont Pharmaceutical Holdings
North America, California, United States, San Jose
Co-Investments: 1
PC
Puissance Capital
North America, New York, United States, New York
Co-Investments: 1
Intermediate Capital Group
Intermediate Capital Group
Europe, England, United Kingdom, London
Co-Investments: 1
Point72
Point72
North America, Connecticut, United States, Stamford
Co-Investments: 1
LifeArc
LifeArc
Europe, England, United Kingdom, London
Co-Investments: 1
Acorn Bioventures
Acorn Bioventures
North America, New York, United States, New York
Co-Investments: 1
Armistice Capital
Armistice Capital
North America, New York, United States, New York
Co-Investments: 1

Which angels does Samlyn Capital often collaborate with?

RA
Richard A Miller
North America, United States
Shared Deals: 1

What are some of recent deals done by Samlyn Capital?

PureCycle Technologies

Ironton, Ohio, United States

PureCycle Technologies offers the only recycled polypropylene with properties equal to virgin polymer.

Chemical EngineeringRecyclingWaste Management
Post Ipo EquityFeb 5, 2025
Amount Raised: $33,000,000
Celcuity

Hamel, Minnesota, United States

Celcuity is a biotechnology company translating discoveries of new cancer sub-types into expanded therapeutic options for cancer patients.

BiotechnologyHealth CareHealth DiagnosticsTherapeutics
Post Ipo EquityMay 30, 2024
Amount Raised: $60,000,000
Corvus Pharmaceuticals

Burlingame, California, United States

Corvus Pharmaceuticals is a clinical-stage biopharmaceutical company.

BiopharmaBiotechnologyPharmaceutical
Post Ipo EquityMay 2, 2024
Amount Raised: $30,600,000
Eliem Therapeutics

Redmond, Washington, United States

Eliem Therapeutics is a clinical-stage biotechnology company developing treatments for nervous system disorders.

BiotechnologyHealth CarePharmaceutical
Series BMay 24, 2021
Amount Raised: $60,000,000
PureCycle Technologies

Ironton, Ohio, United States

PureCycle Technologies offers the only recycled polypropylene with properties equal to virgin polymer.

Chemical EngineeringRecyclingWaste Management
Post Ipo EquityMar 18, 2021
Amount Raised: $250,000,000
Applied Minerals

New York, New York, United States

Applied Minerals produces halloysite clay with commercially consistent product grades.

CommercialManufacturingMineral
Post Ipo EquityJun 27, 2011
Amount Raised: $12,000,000
c-shape-1
c-shape-2

Ready to Raise Capital?

Founders in our network have raised from Y Combinator, Sequoia, a16z, and more. You could be next.

Find investors

Pages

Find investorsPricing

Free tools

Pre-Money and Post-Money Valuation Calculator